Author

Elena Sánchez-Escabias

Consejo Superior de Investigaciones Científicas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1 Assay:scATAC-seq· 1

Frequent Co-Authors

Jose C. ReyesiD· 2 shared Ana Reina-Bando· 1 shared Daniel RicoiD· 1 shared G. Vignir HelgasoniD· 1 shared Gema Moreno‐BuenoiD· 1 shared Ignacio G. López-Cepero· 1 shared Jesús María Sierra-PárragaiD· 1 shared Kevin M. RattiganiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Jose C. ReyesORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintMay 4, 2026

Toward a probabilistic definition of chromatin accessible regions at the single-cell level

Elena Sánchez-Escabias, Daniel Rico, Jose C. Reyes

The paper introduces a probabilistic framework to define chromatin accessibility in single-cell snATAC-seq data, avoiding arbitrary thresholds and providing a dynamic understanding of accessible regions.

DOI 10.64898/2026.05.01.722232

scATAC-seqstatistical model

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 11, 2025

FGFR1 inhibition prevents metabolic adaptation associated with therapy resistance in glioblastoma

Laura Zarzuela, Ignacio G. López-Cepero, Kevin M. Rattigan…·Raúl V. Durán

This study identifies FGFR1 as a key driver of TMZ resistance in GBM through metabolic rewiring and cell cycle regulation, showing that FGFR1 inhibition restores TMZ sensitivity in preclinical models.

DOI 10.1101/2025.01.11.632515

humanbulk RNA-seq

𝕏 PostBluesky